PHRRF (PharmaTher Holdings) Total Receivables: $0.01 Mil (As of Feb. 2026)


What is PharmaTher Holdings Total Receivables?

PharmaTher Holdings PHRRF +6.29% Total Receivables is $0.01 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

PharmaTher Holdings's Total Receivables for the quarter that ended in Feb. 2026 was $0.01 Mil.

PharmaTher Holdings Total Receivables Related Terms

PharmaTher Holdings Total Receivables Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings Total Receivables Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
Total Receivables
0.02 0.02 0.04 0.02 0.01

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

PharmaTher Holdings Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.01 Mil mean?
PharmaTher Holdings (PHRRF) has a Total Receivables of $0.01 Mil as of Feb. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PharmaTher Holdings and its competitors.
Is PharmaTher Holdings' Total Receivables too high?
PharmaTher Holdings' current Total Receivables is $0.01 Mil.
How does PharmaTher Holdings' Total Receivables compare to VRTX and REGN?
PharmaTher Holdings' Total Receivables of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current Total Receivables is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current Total Receivables of $0.01 Mil. The current Total Receivables is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current Total Receivables is $0.01 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.